ProPhase Labs Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
405.00
7,834.00
3,600.00
2,868.00
40,589.00
1,740
Depreciation, Depletion & Amortization
243.00
277.00
367.00
426.00
337.00
383
Other Funds
-
100.00
-
-
-
934
Funds from Operations
917.00
2,942.00
3,107.00
2,417.00
2,417.00
423
Changes in Working Capital
220.00
274.00
390.00
1,945.00
421.00
1,696
Net Operating Cash Flow
1,137.00
3,216.00
3,497.00
472.00
2,838.00
2,119
Capital Expenditures
442.00
312.00
718.00
651.00
208.00
Sale of Fixed Assets & Businesses
-
6.00
9.00
-
40,825.00
Purchase/Sale of Investments
-
-
-
-
18,843.00
Net Investing Cash Flow
442.00
306.00
709.00
651.00
21,774.00
Issuance/Reduction of Debt, Net
100.00
-
1,380.00
100.00
1,500.00
Net Financing Cash Flow
371.00
4,810.00
2,944.00
100.00
16,204.00
Net Change in Cash
1,066.00
1,288.00
1,262.00
1,223.00
2,732.00
Free Cash Flow
695.00
3,528.00
4,215.00
1,123.00
3,046.00
Change in Capital Stock
471.00
4,910.00
1,564.00
-
14,704.00

About ProPhase Labs

View Profile
Address
621 North Shady Retreat Road
Doylestown Pennsylvania 18901
United States
Employees -
Website http://www.prophaselabs.com
Updated 07/08/2019
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products, dietary supplements, and other remedies. Its products include TK supplement and Organix Rx. The company was founded by Guy J.